J&J to sell diagnostics unit to Carlyle for $4.15 bln

Johnson & Johnson said on Thursday it will sell its ortho clinical diagnostics unit to private equity firm Carlyle Group for $4.15 billion, a year after announcing it was considering spinning off or selling the slow-growing business, sister news service Reuters reported.